Sunovion Pharmaceuticals
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. SunovionÍs spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. SunovionÍs track record of discovery, development and commercialization of important therapies has included Brovana¬ (arformoterol tartrate), Latuda¬ (lurasidone HCI), and most recently Aptiom¬ (eslicarbazepine acetate). Headquartered in Marlborough, Mass. Sunovion is an indirect, wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc. Additional information can be found on the CompanyÍs web sites: www.sunovion.com, www.sunovion.eu and www.sunovion.ca. Connect with Sunovion on Twitter @Sunovion and LinkedIn. LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd. APTIOM is used under license from BIAL. BROVANA is a registered trademark of Sunovion Pharmaceuticals Inc. © 2016 Sunovion Pharmaceuticals Inc.
Pharmaceuticals
About

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. SunovionÍs spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. SunovionÍs track record of discovery, development and commercialization of important therapies has included Brovana¬ (arformoterol tartrate), Latuda¬ (lurasidone HCI), and most recently Aptiom¬ (eslicarbazepine acetate).

Headquartered in Marlborough, Mass. Sunovion is an indirect, wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Europe Ltd., based in London, England, and Sunovion Pharmaceuticals Canada, Inc., based in Mississauga, Ontario, are wholly-owned direct subsidiaries of Sunovion Pharmaceuticals Inc. Additional information can be found on the CompanyÍs web sites: www.sunovion.com, www.sunovion.eu and www.sunovion.ca. Connect with Sunovion on Twitter @Sunovion and LinkedIn.

LATUDA is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd.
APTIOM is used under license from BIAL.
BROVANA is a registered trademark of Sunovion Pharmaceuticals Inc.

© 2016 Sunovion Pharmaceuticals Inc.

Site Traffic
  • 3600280 Global Rank
  • 809596
    United States
Traffic Sources
  • Direct
    61.63%
  • Search
    37.08%
  • Social
    1.29%
  • Display
    0.00%
  • Mail
    0.00%
  • Referrals
    0.00%
Powered by
Alexa Traffic Data
Global Rank 581,990
3,582,269
United States Rank 172,085
158
United States Page Views 100.0%
0.9%
Top Countries
Top Search Keywords
  • Français
  • Routier
Mobile App Data
MixRank is the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn more.
  • 10 K Downloads
  • 10 SDKs
  • 3.93 Avg. Rating
  • 15 Total reviews
  • App Url: https://play.google.com/store/apps/details?id=com.sunovion.lunatracker
  • App Support: http://www.lunesta.com
  • Genre: health_and_fitness
  • Bundle ID: com.sunovion.lunatracker
  • App Size: 10.4 M
  • Version: 4
  • Release Date: July 22nd, 2013
  • Update Date: September 16th, 2013

Description:

Millions of us struggle with sleeplessness. If you are one of them, take on your challenges with the free Luna Tracker™ app.

A COMPREHENSIVE SLEEP TRACKER

* TRACK YOUR SLEEP
Keep track of how many hours you sleep and how many times you wake up during the night.

* WAKE UP WHEN YOU’RE READY
Use the Luna Alarm to help wake you up during a light stage of sleep, when your body is more ready to wake up.

* SEE YOUR PATTERNS
Review a nightly graph of your movement during the night, which may indicate sleep stages you may have gone through.

* LOG DAILY ACTIVITY
Record things like caffeine consumption, exercise, naps and relaxation to see how they may affect your sleep.


Project Luna™ and the Luna Tracker™ are brought to you by Sunovion Pharmaceuticals Inc. and LUNESTA® (eszopiclone), because we understand that a healthy sleep routine can work alongside medication to help manage insomnia* – a medical condition in which problems with falling asleep and/or staying asleep have a negative impact on the next day.

*In clinical studies LUNESTA was proven effective to help the majority of patients with insomnia fall asleep quickly and stay asleep for up to 7 hours. Individual results may vary. www.lunesta.com

The Luna Tracker™ is for your personal use only. By using the Luna Tracker™ you understand and acknowledge the information that you put into the Luna Tracker™ will not be accessed by anyone other than you, unless you choose to share it with someone else.

Please note that all comments posted on Google Play are not associated with or endorsed by Sunovion Pharmaceuticals Inc.

If you have any questions, please contact Sunovion Pharmaceuticals Inc. directly at 1-888-394-7377. If you are experiencing a medical emergency, contact your doctor immediately or call 911.

INDICATION
Lunesta® (eszopiclone) is a prescription sleep medicine used in adults for the treatment of a sleep problem called insomnia. Symptoms of insomnia include trouble falling asleep and waking up often during the night.

IMPORTANT SAFETY INFORMATION
LUNESTA acts quickly, so take it right before bed, and only if you have 8 hours to devote to sleep. Do not take LUNESTA if you are allergic to anything in it. LUNESTA should not be taken together with alcohol. Until you know how you will react to LUNESTA, you should not drive or operate machinery. Call your doctor if your insomnia worsens or is not better within 7 to 10 days. This may mean that there is another condition causing your sleep problems. Walking, eating, driving or engaging in other activities while asleep without remembering it the next day have been reported. Other abnormal behaviors include aggressiveness, agitation, hallucinations and confusion. In depressed patients, worsening of depression including risk of suicide may occur. These risks may increase if you drink alcohol. Severe allergic reactions such as swelling of the tongue and throat occur rarely and may be fatal. Call your doctor if you experience these or any effects or reactions that concern you. LUNESTA, like most sleep medicines, carries some risk of dependency. Side effects may include unpleasant taste, headache, morning drowsiness and dizziness.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. For more information, please see the LUNESTA Medication Guide [http://www.lunesta.com/pdf/lunesta-patient-medication-guide.pdf] and Full Prescribing Information [http://www.lunesta.com/pdf/PostedApprovedLabelingText.pdf].

LUNESTA is a registered trademark and (moth), PROJECT LUNA, and LUNA TRACKER are trademarks of Sunovion Pharmaceuticals Inc. © 2013 Sunovion Pharmaceuticals Inc. All rights reserved. 7/13 LUN176-13

AChartEngine
Charting library for Android applications. Automatically exported from code.google.com/p/achartengine
ActionBarSherlock
Deprecated ActionBarSherlock is an extension of the support library designed to facilitate the use of the action bar design pattern across all versions of Android with a single API.
Android API
The Android platform provides a framework API that applications can use to interact with the underlying Android system. The framework API consists of: A core set of packages and classes. A set of permissions that applications can request, as well as permission enforcements included in the system
Facebook
The Facebook SDK for Android is the easiest way to integrate your Android app with Facebook's platform. The SDK provides support for Login with Facebook authentication, reading and writing to Facebook APIs and support for UI elements such as pickers and dialogs.
Google Play Services
Google Play services powers a broad set of SDKs on Android to help you build your app, enhance privacy and security, engage users, and grow your business. These SDKs are unique in that they only require a thin client library to be included in your app, as shown in figure 1. At runtime, the client library communicates with the bulk of the SDK's implementation and footprint in Google Play services.
GreenRobot greenDAO
greenDAO is an open source Android ORM making development for SQLite databases fun again. It relieves developers from dealing with low-level database requirements while saving development time. SQLite is an awesome embedded relational database. Still, writing SQL and parsing query results are quite tedious and time-consuming tasks. greenDAO frees you from these by mapping Java objects to database tables (called ORM, “object/relational mapping”). This way you can store, update, delete, and query for Java objects using a simple object oriented API.
InMobi
Leverage InMobi’s technology platform and exclusive access to mobile intelligence, and create new paths to understand, identify, engage and acquire consumers.
NineOldAndroids
Depricated Android library for using the Honeycomb (Android 3.0) animation API on all versions of the platform back to 1.0! Animation prior to Honeycomb was very limited in what it could accomplish so in Android 3.x a new API was written. With only a change in imports, we are able to use a large subset of the new-style animation with exactly the same API. This library also includes support for animating rotation, translation, alpha, and scale on platforms prior to Honeycomb!
SessionM
SessionM offers a new approach that helps you cultivate users’ loyalty and earn more from their attention. Our platform makes it easy for developers and publishers to promote and monetize high-value activities, using easy-to-understand achievement structures, status sharing and real-world rewards. When users get value for their time, they gladly spend more of it with your content and ads.
ViewPagerIndicator
Paging indicator widgets compatible with the ViewPager from the Android Support Library and ActionBarSherlock.Paging indicator widgets that are compatible with the ViewPager from the Android Support Library to improve discoverability of content.
Data sourced from MixRank, the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn More.
Sunovion Pharmaceuticals receives up to 0.02M pageviews per day.

They have 13 advertising & marketing contacts listed on Kochava. Sunovion Pharmaceuticals works with Advertising technology companies such as Atlas, DoubleClick.Net, Google AdSense Custom Search Ads, Google Adsense, Facebook Custom Audiences, Google Remarketing, Twitter Ads.